Neurovascularization inhibiting dual responsive hydrogel for alleviating the progression of osteoarthritis

Abstract Treating osteoarthritis (OA) associated pain is a challenge with the potential to significantly improve patients lives. Here, we report on a hydrogel for extracellular RNA scavenging and releasing bevacizumab to block neurovascularization at the osteochondral interface, thereby mitigating O...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenpin Qin, Zhangyu Ma, Guo Bai, Wen Qin, Ling Li, Dongxiao Hao, Yuzhu Wang, Jianfei Yan, Xiaoxiao Han, Wen Niu, Lina Niu, Kai Jiao
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-025-56727-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823861786298810368
author Wenpin Qin
Zhangyu Ma
Guo Bai
Wen Qin
Ling Li
Dongxiao Hao
Yuzhu Wang
Jianfei Yan
Xiaoxiao Han
Wen Niu
Lina Niu
Kai Jiao
author_facet Wenpin Qin
Zhangyu Ma
Guo Bai
Wen Qin
Ling Li
Dongxiao Hao
Yuzhu Wang
Jianfei Yan
Xiaoxiao Han
Wen Niu
Lina Niu
Kai Jiao
author_sort Wenpin Qin
collection DOAJ
description Abstract Treating osteoarthritis (OA) associated pain is a challenge with the potential to significantly improve patients lives. Here, we report on a hydrogel for extracellular RNA scavenging and releasing bevacizumab to block neurovascularization at the osteochondral interface, thereby mitigating OA pain and disease progression. The hydrogel is formed by cross-linking aldehyde-phenylboronic acid-modified sodium alginate/polyethyleneimine-grafted protocatechuic acid (OSAP/PPCA) and bevacizumab sustained-release nanoparticles (BGN@Be), termed OSPPB. The dynamic Schiff base bonds and boronic ester bonds allow for injectability, self-healing, and pH/reactive oxygen species dual responsiveness. The OSPPB hydrogel can significantly inhibit angiogenesis and neurogenesis in vitro. In an in vivo OA model, intraarticular injection of OSPPB accelerates the healing process of condyles and alleviates chronic pain by inhibiting neurovascularization at the osteochondral interface. The injectable hydrogel represents a promising technique to treat OA and OA associated pain.
format Article
id doaj-art-236efb198c69435fbcd5143c3926b40a
institution Kabale University
issn 2041-1723
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj-art-236efb198c69435fbcd5143c3926b40a2025-02-09T12:44:06ZengNature PortfolioNature Communications2041-17232025-02-0116111710.1038/s41467-025-56727-8Neurovascularization inhibiting dual responsive hydrogel for alleviating the progression of osteoarthritisWenpin Qin0Zhangyu Ma1Guo Bai2Wen Qin3Ling Li4Dongxiao Hao5Yuzhu Wang6Jianfei Yan7Xiaoxiao Han8Wen Niu9Lina Niu10Kai Jiao11Department of Stomatology, Tangdu Hospital, The Fourth Military Medical UniversityDepartment of Stomatology, Tangdu Hospital, The Fourth Military Medical UniversityDepartment of Oral Surgery, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of MedicineState Key Laboratory of Oral and Maxillofacial Reconstruction and Regeneration, The Fourth Military Medical UniversityState Key Laboratory of Oral and Maxillofacial Reconstruction and Regeneration, The Fourth Military Medical UniversityState Key Laboratory of Oral and Maxillofacial Reconstruction and Regeneration, The Fourth Military Medical UniversityState Key Laboratory of Oral and Maxillofacial Reconstruction and Regeneration, The Fourth Military Medical UniversityState Key Laboratory of Oral and Maxillofacial Reconstruction and Regeneration, The Fourth Military Medical UniversityDepartment of Stomatology, Tangdu Hospital, The Fourth Military Medical UniversityState Key Laboratory of Oral and Maxillofacial Reconstruction and Regeneration, The Fourth Military Medical UniversityState Key Laboratory of Oral and Maxillofacial Reconstruction and Regeneration, The Fourth Military Medical UniversityDepartment of Stomatology, Tangdu Hospital, The Fourth Military Medical UniversityAbstract Treating osteoarthritis (OA) associated pain is a challenge with the potential to significantly improve patients lives. Here, we report on a hydrogel for extracellular RNA scavenging and releasing bevacizumab to block neurovascularization at the osteochondral interface, thereby mitigating OA pain and disease progression. The hydrogel is formed by cross-linking aldehyde-phenylboronic acid-modified sodium alginate/polyethyleneimine-grafted protocatechuic acid (OSAP/PPCA) and bevacizumab sustained-release nanoparticles (BGN@Be), termed OSPPB. The dynamic Schiff base bonds and boronic ester bonds allow for injectability, self-healing, and pH/reactive oxygen species dual responsiveness. The OSPPB hydrogel can significantly inhibit angiogenesis and neurogenesis in vitro. In an in vivo OA model, intraarticular injection of OSPPB accelerates the healing process of condyles and alleviates chronic pain by inhibiting neurovascularization at the osteochondral interface. The injectable hydrogel represents a promising technique to treat OA and OA associated pain.https://doi.org/10.1038/s41467-025-56727-8
spellingShingle Wenpin Qin
Zhangyu Ma
Guo Bai
Wen Qin
Ling Li
Dongxiao Hao
Yuzhu Wang
Jianfei Yan
Xiaoxiao Han
Wen Niu
Lina Niu
Kai Jiao
Neurovascularization inhibiting dual responsive hydrogel for alleviating the progression of osteoarthritis
Nature Communications
title Neurovascularization inhibiting dual responsive hydrogel for alleviating the progression of osteoarthritis
title_full Neurovascularization inhibiting dual responsive hydrogel for alleviating the progression of osteoarthritis
title_fullStr Neurovascularization inhibiting dual responsive hydrogel for alleviating the progression of osteoarthritis
title_full_unstemmed Neurovascularization inhibiting dual responsive hydrogel for alleviating the progression of osteoarthritis
title_short Neurovascularization inhibiting dual responsive hydrogel for alleviating the progression of osteoarthritis
title_sort neurovascularization inhibiting dual responsive hydrogel for alleviating the progression of osteoarthritis
url https://doi.org/10.1038/s41467-025-56727-8
work_keys_str_mv AT wenpinqin neurovascularizationinhibitingdualresponsivehydrogelforalleviatingtheprogressionofosteoarthritis
AT zhangyuma neurovascularizationinhibitingdualresponsivehydrogelforalleviatingtheprogressionofosteoarthritis
AT guobai neurovascularizationinhibitingdualresponsivehydrogelforalleviatingtheprogressionofosteoarthritis
AT wenqin neurovascularizationinhibitingdualresponsivehydrogelforalleviatingtheprogressionofosteoarthritis
AT lingli neurovascularizationinhibitingdualresponsivehydrogelforalleviatingtheprogressionofosteoarthritis
AT dongxiaohao neurovascularizationinhibitingdualresponsivehydrogelforalleviatingtheprogressionofosteoarthritis
AT yuzhuwang neurovascularizationinhibitingdualresponsivehydrogelforalleviatingtheprogressionofosteoarthritis
AT jianfeiyan neurovascularizationinhibitingdualresponsivehydrogelforalleviatingtheprogressionofosteoarthritis
AT xiaoxiaohan neurovascularizationinhibitingdualresponsivehydrogelforalleviatingtheprogressionofosteoarthritis
AT wenniu neurovascularizationinhibitingdualresponsivehydrogelforalleviatingtheprogressionofosteoarthritis
AT linaniu neurovascularizationinhibitingdualresponsivehydrogelforalleviatingtheprogressionofosteoarthritis
AT kaijiao neurovascularizationinhibitingdualresponsivehydrogelforalleviatingtheprogressionofosteoarthritis